132 related articles for article (PubMed ID: 10225730)
1. Comparison of the adsorption ability between tryptophan and modified tryptophan columns.
Odaka M; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):353-5. PubMed ID: 10225730
[TBL] [Abstract][Full Text] [Related]
2. [Removal ability of anti-ganglioside antibodies in immunoadsorption using a modified tryptophan-immobilized column].
Tagawa Y; Yuki N; Hirata K
Rinsho Shinkeigaku; 1997 Oct; 37(10):863-7. PubMed ID: 9490893
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan-immobilized column adsorbs immunoglobulin G anti-GQ1b antibody from Fisher's syndrome: A new approach to treatment.
Yuki N
Neurology; 1996 Jun; 46(6):1644-51. PubMed ID: 8649564
[TBL] [Abstract][Full Text] [Related]
4. [Removal ability of IgG anti-GQ1b antibody in immunoadsorption therapy for Fisher syndrome--comparison of the removal ability between tryptophane column and phenylalanine column].
Ichikawa H; Suzuki M; Kawamura M; Sugita K; Watanabe Y; Yuki N
Rinsho Shinkeigaku; 1996 Feb; 36(2):323-9. PubMed ID: 8752688
[TBL] [Abstract][Full Text] [Related]
5. [Immunoadsorption therapy with TR-350 (tryptophan column) for Guillain-Barré syndrome: investigation including serum antiganglioside antibody assay].
Araki T; Nakata H; Kusunoki S; Arai Y; Katayama Y
Rinsho Shinkeigaku; 2000 Oct; 40(10):979-85. PubMed ID: 11296374
[TBL] [Abstract][Full Text] [Related]
6. Immunoadsorption therapy for Fisher syndrome associated with IgG anti-GQ1b antibody.
Ohtsuka K; Nakamura Y; Tagawa Y; Yuki N
Am J Ophthalmol; 1998 Mar; 125(3):403-6. PubMed ID: 9512167
[TBL] [Abstract][Full Text] [Related]
7. [Immunoadsorption therapy on Fisher's syndrome--removal ability of anti-ganglioside antibodies by tryptophan-linked immunoadsorbent].
Deguchi K; Takeuchi H; Takahashi N; Yuki N
Rinsho Shinkeigaku; 1995 Aug; 35(8):884-8. PubMed ID: 8665731
[TBL] [Abstract][Full Text] [Related]
8. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
9. Spectrum of neurological diseases associated with antibodies to minor gangliosides GM1b and GalNAc-GD1a.
Tatsumoto M; Koga M; Gilbert M; Odaka M; Hirata K; Kuwabara S; Yuki N
J Neuroimmunol; 2006 Aug; 177(1-2):201-8. PubMed ID: 16844234
[TBL] [Abstract][Full Text] [Related]
10. [Immunoadsorption therapy for Fisher's syndrome: analysis of the recovery process of external ophthalmoplegia and the removal ability of anti-GQ1b antibodies].
Chida K; Watanabe S; Okita N; Takase S; Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1996 Apr; 36(4):551-6. PubMed ID: 8810848
[TBL] [Abstract][Full Text] [Related]
11. Recent developments in Miller Fisher syndrome and related disorders.
Overell JR; Willison HJ
Curr Opin Neurol; 2005 Oct; 18(5):562-6. PubMed ID: 16155441
[TBL] [Abstract][Full Text] [Related]
12. Antiganglioside antibodies in Guillain-Barré syndrome and its related conditions.
Shahrizaila N; Yuki N
Expert Rev Neurother; 2011 Sep; 11(9):1305-13. PubMed ID: 21864076
[TBL] [Abstract][Full Text] [Related]
13. Bickerstaff's brainstem encephalitis associated with IgG anti-GQ1b antibody subsequent to Mycoplasma pneumoniae infection: favorable response to immunoadsorption therapy.
Kikuchi M; Tagawa Y; Iwamoto H; Hoshino H; Yuki N
J Child Neurol; 1997 Sep; 12(6):403-5. PubMed ID: 9309527
[No Abstract] [Full Text] [Related]
14. Development of facial palsy during immunoadsorption plasmapheresis in Miller Fisher syndrome: a clinical report of two cases.
Chida K; Takase S; Itoyama Y
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):399-401. PubMed ID: 9527160
[TBL] [Abstract][Full Text] [Related]
15. Ability to remove immunoglobulins and antiganglioside antibodies by double filtration plasmapheresis in Guillain-Barré syndrome: is it equivalent to plasma exchange?
Tagawa Y; Yuki N; Hirata K
Ther Apher; 1997 Nov; 1(4):336-9. PubMed ID: 10225726
[TBL] [Abstract][Full Text] [Related]
16. [Antiganglioside antibodies: when, which and for what].
Gallardo E; Rojas-García R; Belvís R; Serrano-Munuera C; Ortiz E; Ortiz N; Grau J; Illa I
Neurologia; 2001; 16(7):293-7. PubMed ID: 11485721
[TBL] [Abstract][Full Text] [Related]
17. Anti-ganglioside antibody and neuropathy: review of our research.
Yuki N
J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
[TBL] [Abstract][Full Text] [Related]
18. [A case of Guillain-Barré syndrome associated with bilateral ballism: an overlap between Fisher's syndrome and Guillain-Barré syndrome].
Odaka M; Yuki N; Arai M; Hirata K
Rinsho Shinkeigaku; 1998 Aug; 38(8):745-9. PubMed ID: 9916521
[TBL] [Abstract][Full Text] [Related]
19. [High-dose intravenous immunoglobulin therapy in a child case of Bickerstaff's brainstem encephalitis].
Sugiyama N; Hamano S; Koga M
No To Hattatsu; 2003 Jul; 35(4):327-30. PubMed ID: 12875210
[TBL] [Abstract][Full Text] [Related]
20. [A case of relapsing Guillain-Barré syndrome following Miller Fisher syndrome].
Mochizuki A; Ota K; Iijima M; Yamauchi T; Iwata M
Rinsho Shinkeigaku; 1996 May; 36(5):675-9. PubMed ID: 8905988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
